Ultrasound enhancement of fibrinolysis

Stroke

Volumn 40, Issue 3 SUPPL. 1, 2009, Pages

  Alexandrov, Andrei V ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b RWUH M226 619 ^*  (United States)

Author keywords

Outcomes; Stroke; Thrombolysis; tPA; Ultrasound

Indexed keywords

CONTRAST MEDIUM; FIBRINOLYTIC AGENT; MICROSPHERE; PERFLUTREN; SHU 508; SONOVUE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; BLEEDING; BRAIN ANGIOGRAPHY; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CATHETER; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONFERENCE PAPER; DIGITAL SUBTRACTION ANGIOGRAPHY; DOPPLER ECHOGRAPHY; DRUG DELIVERY SYSTEM; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; FIBRINOLYTIC THERAPY; HUMAN; IMAGE QUALITY; MAGNETIC RESONANCE ANGIOGRAPHY; NEUROIMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; STROKE; TREATMENT OUTCOME; ULTRASOUND;

FIBRINOLYSIS; FIBRINOLYTIC AGENTS; HUMANS; INTRACRANIAL THROMBOSIS; STROKE; TISSUE PLASMINOGEN ACTIVATOR; ULTRASONICS;

EID: 62949227454     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.530931     Document Type: Conference Paper

References (38)

1. The National Institutes of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
2. Saqqur M, Uchino K, Demchuk AM, Molina CA, Garami Z, Calleja S, Akhtar N, Orouk FO, Salam A, Shuaib A, Alexandrov AV. Site of arterial occlusion identified by transcranial Doppler (TCD) predicts the response to intravenous thrombolysis for stroke. Stroke. 2007;38:948-954.
3. Christou I, Felberg RA, Demchuk AM, Burgin WS, Grotta JC, Malkoff M, Alexandrov AV. Intravenous tissue plasminogen activator and flow improvement in acute ischemic stroke patients with internal carotid artery occlusion. J Neuroimaging. 2002;12:119-123.
4. The IMS II Study Investigators. The Interventional Management of Stroke (IMS II) Study. Stroke. 2007;38:2127-2135.
5. Alexandrov AV, Demchuk AM, Felberg RA, Christou I, Barber PA, Burgin WS, Malkoff M, Wojner AW, Grotta JC. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored by 2-MHz transcranial Doppler monitoring. Stroke. 2000;31:610-614.
6. Alexandrov AV, Burgin WS, Demchuk AM, El-Mitwalli A, Grotta JC. Speed of intracranial clot lysis with intravenous tPA therapy: sonographic classification and short-term improvement. Circulation. 2001;103: 2897-2902.
7. Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, Montaner J, Saqqur M, Demchuk AM, Moye LA, Hill MD, Wojner AW. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med. 2004;351:2170-2178.
8. Francis CW. Ultrasound-enhanced thrombolysis. Echocardiography. 2001;18:239-246.
9. Lauer CG, Burge R, Tang DB, Bass BG, Gomez ER, Alving BM. Effect of ultrasound on tissue-type plasminogen activator-induced thrombolysis. Circulation. 1992;86:1257-1264.
10. Kimura M, Iijima S. Kobayashi K, Furuhata H. Evaluation of the thrombolytic effect of tissue-type plasminogen activator with ultrasound irradiation: in vitro experiment involving assay of the fibrin degradation products from the clot. Biol Pharm Bull. 1994;17:126-130.
11. Blinc A, Francis CW, Trudnowski JL, Carstensen EL. Characterization of ultrasound-potentiated fibrinolysis in vitro. Blood. 1993;81:2636-2643.
12. Suchkova V, Siddiqi FN, Carstensen EL, Dalecki D, Child S, Francis CW. Enhancement of fibrinolysis with 40-kHz ultrasound. Circulation. 1998;98:1030-1035.
13. Molina CA, Montaner J, Abilleira S, Ibarra B, Romero F, Arenillas JF, Alvarez-Sabin J, Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke. Stroke. 2001;32: 1079-1084.
14. Eggers J, Koch B, Meyer K, Konig I, Seidel G. Effect of ultrasound on thrombolysis of middle cerebral artery occlusion. Ann Neurol. 2003;53: 797-800.
15. Tsivgoulis G, Molina CA, Eggers J, Perren F, Rubiera M, Larrue V, Alexandrov AV. Safety and efficacy of ultrasound-enhanced thrombolysis: a meta-analysis of randomized and nonrandomized studies. Stroke. 2008;39:593-594.
16. Demchuk AM, Burgin WS, Christou I, Felberg RA. Barber PA, Hill MD, Alexandrov AV. Thrombolysis in Brain Ischemia (TIBI) TCD flow grades predict clinical severity, early recovery, and mortality in intravenous tPA-treated patients. Stroke. 2001;32:89-93.
17. Cintas P, Le Traon AP, Larrue V. High rate of recanalization of middle cerebral artery occlusion during 2-MHz transcranial color-coded Doppler continuous monitoring without thrombolytic drug. Stroke 2002;33: 626-628.
18. Alexandrov A, Schafer M. Operator-independent device for sonothrombolysis. Cerebrovasc Dis. 2008;26(suppl 1):6. Abstract.
19. Daffertshofer M, Gass A, Ringleb P, Sitzer M, Sliwka U, Els T, Sedlaczek O, Koroshetz WJ, Hennerici MG. Transcranial low-frequency ultrasound-mediated thrornbolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator. Stroke. 2005;36:1441-1446.
20. Hamof S, Schiff G, Hananel A, Gringeld G. Zadicario E, Zibly Z. Trans-skull clot lysis-proof of concept. Cerebrovas Dis. 2008;26(suppl 1):12.
21. Tomsick T, Broderick J. Carrozella J, Khatri P. Hill M, Palesch Y, Khoury J; Interventional Management of Stroke II Investigators. Revascularization results in the Interventional Management of Stroke II trial. AJNR Am J Neuroradiol. 2008;29:582-587.
22. Alonso A, Della Martina A, Stroick M, Fatar M, Griebe M, Pochon S, Schneider M, Hennerici M, Allémann E, Meairs S. Molecular imaging of human thrombus with novel abciximab immunobubbles and ultrasound. Stroke. 2007;38:1508-1514.
23. Vignon F, Arnal B, Shi W, Brukcer M, Powers J. Mapping the acoustical transparency of the skull. Cerebrovasc Dis. 2008;26(suppl 1):13. Abstract.
24. Tanter M, Couture O, Fink M. Time reversal of acoustic waves in the nonlinear regime: basic physics and application to ultrasound contrast imaging. J Acoust Soc Am. 2008;123:3830.
25. Hoelscher T, Tu E, Ackley D. Development of an acoustically active tPA drug carrier: experiences with a first prototype. Cerebrovasc Dis. 2008; 26(suppl 1):15-16, Abstract.
26. Shaw GJ, Meunier JM, Lindsell CJ, Holland CK. Tissue plasminogen activator concentration dependence of 120 kHz ultrasound-enhanced thrombolysis. Ultrasound Med Biol 2008; May 10. Epub ahead of print.
27. http://www.mbib.nih.gov/nibib/File/About%20NIBIB/NACBIB% 20Meeting%20Files/200801/Final_January_25_2008_Council_Minutes.pdf. Last accessed July 7, 2008.
28. Tsivgoulis G. Alexandrov AV. Ultrasound-enhanced thrombolysis: from bedside to bench. Stroke. 2008;39:1404-1405.
29. http://strokecenter.org/trials/TrialDetail.aspx?tid=747. Last accessed July 7, 2008.
30. Saqqur M, Tsivgoulis G, Molina CA, Demchuk AM, Garami Z, Barreto A, Spengos K, Forteza A, Mikulik R, Sharma VK, Brunser A, Martinez P, Montaner J, Kohrmann M, Schellinger PD, Alexandrov AV. Design of a PROspective multi-national collaboration on reperfusion therapies for stroke (CLOTBUST-PRO). Intl J Stroke. 2008;3:66-72.
31. Molina CA, Ribo M, Rubiera M, Montaner J, Santamarina E, Delgado-Mederos R, Arenillas JF. Huertas R, Purroy F, Delgado P, Alvarez-Sabin J. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke. 2006;37:425-429.
32. Rubiera M, Ribo M, Delgado-Mederos R, Santamarina E, Maisterra O, Delgado P, Montaner J, Alvarez-Sabín J, Molina CA. Do bubble characteristics affect recanalization in stroke patients treated with microbubble-enhanced sonothrombolysis? Ultrasound Med Biol. 2008;34;1573-1577.
33. Dayton PA, Morgan KE, Klibanov AL, Brandenburger GH, Ferrara KW. Optical and acoustical observations of the effects of ultrasound on contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control. 1999;46:220-232.
34. Sharma VK, Tsivgoulis G, Lao AY, Malkoff MD, Alexandrov AW, Alexandrov AV. Quantification of microspheres (μS) appearance in brain vessels: implications for residual flow velocity measurements, dose calculations, and potential drug delivery. Stroke. 2008;39:1476-1481.
35. Xie F, Tsutsui JM, Lof J, Unger EC, Johanning J, Culp WC, Matsunaga T, Porter TR. Effectiveness of lipid microbubbles and ultrasound in declotting thrombosis. Ultrasound Med Biol. 2005;31:979-985.
36. Culp WC, Porter TR, Lowery J, Xie F, Roberson PK, Marky L. Intracranial clot lysis with intravenous microbubbles and transcranial ultrasound in swine. Stroke. 2004;35:2407-2411.
37. Alexandrov AV, Mikulik R, Sharma VK, Lao AY, Tsivgoulis G, Sugg RM, Barreto A, Sierzenski P, Malkoff MD, Grotta JC. A pilot randomized clinical safety study of sonothrombolysis augmentation with ultrasound-activated perflutren-lipid microspheres (μS) for acute ischemic stroke. Stroke. 2008;39:1464-1469.
38. http://www.clinicaltrials.gov/ct2/show/NCT00504842?term=tucson& rank=1. Last accessed July 7, 2008.